The value of hospital personnel serological screening in an integrated COVID-19 infection prevention and control strategy

Filippo Quattrone MD123a , Marco Vabanesi MD4a , Alice Borghini MD5, Giuseppe De Vito MD6, Michele Emdin PhD, MD13 and Claudio Passino MD13 1Institute of Life Sciences, Scuola Superiore Sant’Anna, Pisa, Italy, 2Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy, 3Fondazione Toscana Gabriele Monasterio, Pisa, Italy, 4Department of Neurology, San Raffaele Scientific Institute and University Hospital, Milan, Italy, 5Institute of Management, Scuola Superiore Sant’Anna, Pisa, Italy and 6Fondazione Stella Maris, Pisa, Italy

[1]  X. Tang,et al.  Antibody responses to SARS-CoV-2 in patients with COVID-19 , 2020, Nature Medicine.

[2]  D. Lendrem,et al.  First experience of COVID-19 screening of health-care workers in England , 2020, The Lancet.

[3]  Charles Swanton,et al.  COVID-19: the case for health-care worker screening to prevent hospital transmission , 2020, The Lancet.

[4]  C. Evans,et al.  Roll-out of SARS-CoV-2 testing for healthcare workers at a large NHS Foundation Trust in the United Kingdom, March 2020 , 2020, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[5]  F. Quattrone,et al.  A nosocomial measles outbreak in Italy, February-April 2017 , 2017, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.